Examines antibody persistence in infants and toddlers after immunization, indicating long-term efficacy.
In 2024, WHO recommended pentavalent meningococcal conjugate vaccine (serogroups A, C, W, Y, and X) for routine infant and toddler immunization in the African meningitis belt. At that time, only short-term data were available regarding persistence of elevated bactericidal antibody levels. This report provides data for the 2 years post-immunization.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: